Data-Based Opioid Risk Review in Patients with Chronic Pain: A Retrospective Chart Review

References

• CDC. Drug overdose deaths in the U.S Top 100,000 annually. 2015. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.html
   Google Scholar
• Nahin RL. severe pain in veterans: the effect of age and sex, and comparisons with the general population. J Pain. 2017;18(3):247–54. doi:10.1016/j.jpain.2016.10.021.
   PubMed Web of Science ®Google Scholar
• Lew HL, Otis JD, Tun C, Kerns RD, Clark ME, Cifu DX. Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clinical triad. J Rehabil Res Dev. 2009;46(6):697–702. doi:10.1682/jrrd.2009.01.0006.
   PubMed Web of Science ®Google Scholar
• Bohnert AS, Ilgen MA, Galea S, McCarthy JF, Blow FC. Accidental poisoning mortality among patients in the department of veterans affairs health system. Med Care. 2011;49(4):393–6. doi:10.1097/MLR.0b013e318202aa27.
   PubMed Web of Science ®Google Scholar
• Baser O, Xie L, Mardekian J, Schaaf D, Wang L, Joshi AV. Prevalence of diagnosed opioid abuse and its economic burden in the veterans health administration. Pain Pract. 2013;14(5):437–45. doi:10.1111/papr.12097.
   PubMed Web of Science ®Google Scholar
• Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L. Risk factors for serious prescription opioid-related toxicity or overdose among veterans health administration patients. Pain Med. 2014;15(11):1911–29. doi:10.1111/pme.12480.
   PubMed Web of Science ®Google Scholar
• Gellad WF, Good CB, Shulkin DJ. Addressing the opioid epidemic in the United States. JAMA Intern Med. 2017;177(5):611–2. doi:10.1001/jamainternmed.2017.0147.
   PubMed Web of Science ®Google Scholar
• Comprehensive Addiction and Recovery Act of 2016, Pub. L. No 114–198, Stat. 524. 2016.
   Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC Guideline for prescribing opioids for chronic pain—united states, 2016. MMWR Recomm Rep. 2016;65(1):1–49. doi:10.15585/mmwr.rr6501e1.
   PubMed Web of Science ®Google Scholar
• Rosenberg J, Spevak C. VA/DoD clinical practice guideline for opioid therapy for chronic pain. VA DOD Clin Pract Guidel. 2017;3:1–198.
   Google Scholar
• Oliva EM, Bowe T, Tavakoli S, Martins S, Lewis ET, Paik M, Wiechers I, Henderson P, Harvey M, Avoundjian T, et al. Development and applications of the veterans health administration’s Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychol Serv. 2017;14(1):34–49. doi:10.1037/ser0000099.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Veterans Affairs. Conduct of data-based case reviews of opioid-exposed patients with risk factors. VA Notice 2019–15. 2019.
   Google Scholar
• Sandbrink F, Oliva EM, McMullen TL, Aylor AR, Harvey MA, Christopher ML, Cunningham F, Minegishi T, Emmendorfer T, Perry JM. Opioid prescribing and opioid risk mitigation strategies in the veterans health administration. J Gen Intern Med. 2020;35(Suppl 3):927–34. doi:10.1007/s11606–020–06258–3.
   PubMed Web of Science ®Google Scholar
• Murphy J, Sandbrink F, Johansson M, Spevak C. VA/DoD clinical practice guideline for the use of opioids in the management of chronic pain. VA DOD Clin Pract Guidel. 2022;4:1–177.
   Google Scholar
• Oliva EM, Bowe T, Manhapra A, Kertesz S, Hah JM, Henderson P, Robinson A, Paik M, Sandbrink F, Gordon AJ, et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020;368:m283. doi:10.1136/bmj.m283.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA identifies sudden discontinuation of opioid pain medicines. 2019. https://www.fda.gov/drugs/drug-safety-and-availability/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label-changes#:∼:text=In%20general,%20for%20patients%20who,to%20accomplish%20a%20successful%20taper.
   Google Scholar
• Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. Prescribing Opioids for pain – the new CDC clinical practice guideline. N Engl J Med. 2022;387(22):2011–3. doi:10.1056/NEJMp2211040.
   PubMed Web of Science ®Google Scholar
• Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 2021;326(5):411–9. doi:10.1001/jama.2021.11013.
   PubMed Web of Science ®Google Scholar
• Hallvik SE, El Ibrahimi S, Johnston K, Geddes J, Leichtling G, Korthuis PT, Hartung DM. Patient outcomes after opioid dose reduction among patients with chronic opioid therapy. Pain. 2021;163(1):83–90. doi:10.1097/j.pain.0000000000002298.
   Web of Science ®Google Scholar
• Murphy JL, Clark ME, Banou E. Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment. Clin J Pain. 2013;29(2):109–17. doi:10.1097/AJP.0b013e3182579935.
   PubMed Web of Science ®Google Scholar
• Hill G, Hughes-Stricklett A. Patient outcomes following state-mandated opioid dose reductions. Am J Health Syst Pharm. 2020;77(Supplement_4):S87–S92. doi:10.1093/ajhp/zxaa161.
   PubMedGoogle Scholar
• Hayes CJ, Gressler LE, Hu B, Jones BL, Williams JS, Martin BC. Trajectories of opioid coverage after long-term opioid therapy initiation among a national cohort of US veterans. J Pain Res. 2021;14:1745–62. doi:10.2147/JPR.S308196.
   PubMed Web of Science ®Google Scholar
• Rogal SS, Chinman M, Gellad WF, Mor MK, Zhang H, McCarthy SA, Mauro GT, Hale JA, Lewis ET, Oliva EM, et al. Tracking implementation strategies in the randomized rollout of a Veterans Affairs national opioid risk management initiative. Implement Sci. 2020;15(1):48. doi:10.1186/s13012–020–01005-y.
   PubMed Web of Science ®Google Scholar
• Strombotne KL, Legler A, Minegishi T, Trafton JA, Oliva EM, Lewis ET, Sohoni P, Garrido MM, Pizer SD, Frakt AB. Effect of a predictive analytics-targeted program in patients on opioids: a stepped-wedge cluster randomized controlled trial. J Gen Intern Med. 2022;38(2):375–81. doi:10.1007/s11606–022–07617-y.
   PubMed Web of Science ®Google Scholar